R Saucedo1, G Rico2, G Vega2, L Basurto3, L Cordova3, R Galvan4, M Hernandez3, E Puello5, A Zarate3. 1. Endocrine Research Unit, National Medical Center, IMSS, Cuauhtemoc 330, 06720, Mexico City, Mexico. sgrenata@yahoo.com. 2. Unit of Experimental Medicine, UNAM, Mexico City, Mexico. 3. Endocrine Research Unit, National Medical Center, IMSS, Cuauhtemoc 330, 06720, Mexico City, Mexico. 4. Gerontology Research Unit, UNAM, Mexico City, Mexico. 5. Hospital of Gynecology and Obstetrics, Medical Center La Raza, IMSS, Mexico City, Mexico.
Abstract
OBJECTIVE: To measure serum osteocalcin (OC), under-carboxylated osteocalcin (ucOC), osteopontin (OPN), and leptin in pregnant women with gestational diabetes mellitus (GDM) and in healthy pregnant women during pregnancy and after birth and relate these markers to glucose metabolism. METHODS: This was a prospective study including 60 women with GDM and 60 subjects with normal gestation who were evaluated at gestational week 30 and 6 weeks postpartum. Serum OC, ucOC, OPN, leptin, insulin and insulin resistance were evaluated during the study. RESULTS: Bone biomarkers and leptin were similar between GDM and normal pregnancy. After delivery, OC, ucOC and OPN increased in both groups, while leptin decreased only in healthy controls. Bone markers did not correlate with insulin and insulin resistance in the two groups, but leptin was positively correlated with insulin and insulin resistance and negatively correlated with bone biomarkers only in healthy women. Furthermore, the women who developed diabetes postpartum had lower levels of OC than women with normal glucose tolerance. CONCLUSION: GDM is not associated with OC, ucOC, OPN, and leptin and does not correlate with insulin resistance. At postpartum, women who develop diabetes have lower osteocalcin concentrations. Leptin correlates with insulin resistance and bone biomarkers in non-diabetic women.
OBJECTIVE: To measure serum osteocalcin (OC), under-carboxylated osteocalcin (ucOC), osteopontin (OPN), and leptin in pregnant women with gestational diabetes mellitus (GDM) and in healthy pregnant women during pregnancy and after birth and relate these markers to glucose metabolism. METHODS: This was a prospective study including 60 women with GDM and 60 subjects with normal gestation who were evaluated at gestational week 30 and 6 weeks postpartum. Serum OC, ucOC, OPN, leptin, insulin and insulin resistance were evaluated during the study. RESULTS: Bone biomarkers and leptin were similar between GDM and normal pregnancy. After delivery, OC, ucOC and OPN increased in both groups, while leptin decreased only in healthy controls. Bone markers did not correlate with insulin and insulin resistance in the two groups, but leptin was positively correlated with insulin and insulin resistance and negatively correlated with bone biomarkers only in healthy women. Furthermore, the women who developed diabetes postpartum had lower levels of OC than women with normal glucose tolerance. CONCLUSION: GDM is not associated with OC, ucOC, OPN, and leptin and does not correlate with insulin resistance. At postpartum, women who develop diabetes have lower osteocalcin concentrations. Leptin correlates with insulin resistance and bone biomarkers in non-diabeticwomen.
Authors: Maximilian Zeyda; Karina Gollinger; Jelena Todoric; Florian W Kiefer; Maike Keck; Oskar Aszmann; Gerhard Prager; Gerhard J Zlabinger; Peter Petzelbauer; Thomas M Stulnig Journal: Endocrinology Date: 2011-04-05 Impact factor: 4.736
Authors: Thomas Freude; Karl Friedrich Braun; Alexander Haug; Stefan Pscherer; Ulrich Stöckle; Andreas Klaus Nussler; Sabrina Ehnert Journal: J Mol Med (Berl) Date: 2012-08-29 Impact factor: 4.599
Authors: D E Cole; C M Gundberg; L J Stirk; S A Atkinson; D A Hanley; L M Ayer; L S Baldwin Journal: J Clin Endocrinol Metab Date: 1987-08 Impact factor: 5.958
Authors: Raigam J Martinez-Portilla; Jose R Villafan-Bernal; Diana L Lip-Sosa; Eva Meler; Jordi Clotet; Francisco J Serna-Vela; Sergio Velazquez-Garcia; Leopoldo C Serrano-Diaz; Francesc Figueras Journal: J Diabetes Res Date: 2018-12-30 Impact factor: 4.011